HIV-1 infection and risk of tuberculosis after rifampicin treatment
about
Tuberculosis control in South African gold mines: mathematical modeling of a trial of community-wide isoniazid preventive therapy.Diagnosing latent tuberculosis in high-risk individuals: rising to the challenge in high-burden areas.The sound of one hand clapping: tuberculosis and antiretroviral therapy in Africa.
P2860
HIV-1 infection and risk of tuberculosis after rifampicin treatment
description
article publié dans la revue scientifique The Lancet
@fr
im März 2001 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published in The Lancet
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в березні 2001
@uk
ശാസ്ത്രപ്രബന്ധം
@ml
name
HIV-1 infection and risk of tuberculosis after rifampicin treatment
@en
HIV-1 infection and risk of tuberculosis after rifampicin treatment
@nl
type
label
HIV-1 infection and risk of tuberculosis after rifampicin treatment
@en
HIV-1 infection and risk of tuberculosis after rifampicin treatment
@nl
prefLabel
HIV-1 infection and risk of tuberculosis after rifampicin treatment
@en
HIV-1 infection and risk of tuberculosis after rifampicin treatment
@nl
P2093
P1433
P1476
HIV-1 infection and risk of tuberculosis after rifampicin treatment
@en
P2093
G J Churchyard
K F Mallory
K M De Cock
P304
P356
10.1016/S0140-6736(05)71656-1
P407
P577
2001-03-01T00:00:00Z